Radiopharm Theranostics (RADX) Total Current Liabilities (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Radiopharm Theranostics (RADX) has disclosed Total Current Liabilities for 2 consecutive years, with $14.9 million as the latest value for Q2 2025.

• Quarterly Total Current Liabilities fell 15.04% to $14.9 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $14.9 million through Jun 2025, down 15.04% year-over-year, with the annual reading at $14.9 million for FY2025, 15.04% down from the prior year.
• Total Current Liabilities for Q2 2025 was $14.9 million at Radiopharm Theranostics, down from $17.6 million in the prior quarter.
• The five-year high for Total Current Liabilities was $17.6 million in Q2 2024, with the low at $14.9 million in Q2 2025.

Peer Comparison